Reduced Risk Status: |
|
IPM Compatibility: |
|
Reasons for need: |
|
Requesting State(s): |
HQ:IR-4 Headquarters ;
|
PCR Use Pattern: |
|
EPA Default Residue Trials: |
SNAP: 1 2 3 5-3 10 11; LIMA: 2-4 5 10-2 11
|
IR-4 Residue Trial Plan: |
SNAP: 1 2 3 5-3 10 11; LIMA: 2-4 5 10-2 11(1 must be a decline trial)
|
Residue Protocol Use Pattern: |
|
Efficacy/Crop Safety (E/CS) Data Required: |
|
E/CS Research Comments: |
|
Label Use Pattern Submitted To EPA: |
|
EPA PIF Status: |
|
EPA Status: |
|
EPA PRIA Date: |
|
MRID: |
|
Comments: |
THIS PR# IS ASSOCIATED WITH PR# 11299 AND IS NEEDED FOR STORAGE STABILITY TO ESTABLISH STORAGE STABILITY DATA FOR PR# 11299: 03/23, JPB; Priority A removed as this will be determined if a Red A is needed:09/23/sb; Changed to Priority A for assigning field trials during NRPM 2023; Pending EPA review, may change status: 10/23, JPB; a ChemSAC proposal to EPA was accepted and a residue study is not needed in 2024, so the category has been updated from Researchable, Residue only, to Tolerance/Use to be pursued with no data proposal/petition:01/24/sb
|
International Status: |
|
Archive Location: |
|
QA Archive: |
|